Navigation Links
Marketing and Meeting Details (M2D) Officially Launches an Innovative Life Sciences Marketing and Communications Company
Date:11/19/2007

Clients to Benefit from a Distinctive Union of Pharmaceutical, Biotech and Medical Device Experience in Professional Education, Brand Management and

Special Event Planning

NORTH BRANFORD, Conn., Nov. 19 /PRNewswire/ -- M2D management announces the official launch of a progressive marketing and communications firm that will focus on the life sciences sector. M2D is the brainchild of two individuals with clear records of success in this highly regulated sector, Christine Lawton and Timothy Roe.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071119/NEM104LOGO )

Christine is a respected meetings and events professional with almost two decades of experience working on both the client and agency sides of the business. Her accomplishments span several hundred meetings and conventions of all varieties, both domestically and internationally, during her pharmaceutical tenure.

Timothy is a pharmaceutical and medical device professional with over 15 years of progressively responsible positions in Sales and Marketing. Timothy is known in the industry as having the business acumen to maximize a product's global commercial return and asset value. Timothy has managed the "Big-C" brands, Celebrex(R), Cipro(R) and Clarinex(R) as well as several smaller niche products.

M2D provides tireless proactive thinking that eliminates problems associated with vendor complacency. Timothy Roe adds:

"As a former Product Manager, I recognize what is important to clients. Vendors should always add more detailed and proactive thought to their work, even after the 'honeymoon' period. There continues to be a tremendous need for much higher performance, and smaller firms like M2D are already there. Those who can do it cost-effectively will win."

M2D's uniqueness results from a lifetime of client-side interactions with vendors. Clients receive genuine strategic attention, but the difference lies with M2D's painstakingly detailed approach to tactical execution. The company utilizes the most advanced analytics and metric reporting tools available and offers them either gratis or at attractive pricing.

M2D's core capabilities include:

-- Thorough Understanding of Compliance Laws

-- Lowest Guaranteed Travel Rates

-- Investigator & Sales Meetings

-- Conventions & Symposia; Ad Boards & Round Tables

-- Opinion Leader & Speaker Bureau Management

-- Promotional Peer-to-Peer Events

-- CME-based Programming

-- Surrogate Brand Management and Audits

-- Advanced Webinars & Web Conferences with Real-Time Polling

M2D's website http://www.m2details.com.

Celebrex, Cipro and Clarinex are products of Pfizer, Bayer and Schering- Plough respectively.

Contact: M2D Media Relations

Phone: 781-210-4710

Fax: 781-210-4711

Email: MediaRelations@m2details.com


'/>"/>
SOURCE Marketing and Meeting Details (M2D)
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
2. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
3. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
4. Fitness Champion Natalie Waples to be Spokesperson for Natural Nutrition International Direct Marketing Campaign
5. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
6. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
7. Sterling Life Enhances Marketing Operations Controls to Better Serve Medicare Beneficiaries
8. Former Ronco President Tim Dupler Signs International Direct Sales and Marketing Contract with Natural Nutrition
9. Eastern Alliance Insurance Group Appoints Cox Regional Marketing Director for Southeast
10. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
11. Scientific Publications Strategy & Delivery Shifts from Marketing to Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... 13, 2016 , ... The National Association for Children of ... representing the growing community of recovering individuals (now over 23 million), to issue ... policies addressing addiction. , Although many of the presidential candidates of both ...
(Date:2/13/2016)... FL (PRWEB) , ... February 13, 2016 , ... The ... environmental impact of American businesses. , The increasingly modern world of instantaneous consumption ... often on non-renewable energy sources such as oil and coal, which pollutes our air, ...
(Date:2/13/2016)... ... ... Au Pair comes all the way around the world to provide child care ... often worried things won’t go well. More often than not, however, they find out their ... Year winner’s all commented how their Au Pairs have become a part of the family, ...
(Date:2/12/2016)... ... February 12, 2016 , ... According to an article published ... for a significant portion of hernia repairs throughout the United States. Commenting on this ... Center notes that this trend has not only been expected, but it seems to ...
(Date:2/12/2016)... Seattle, WA, and Washington, DC (PRWEB) , ... ... ... PATH and the Siemens Foundation today announced a new initiative—the Siemens ... technologies for low-resource settings. The partnership will recruit top students from U.S. ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... 2016 Indiso ltd ... ungedeckten medizinischen Bedarf bei Lungen- und Atemwegserkrankungen ... Forschungsprogramms bekannt. Das Programm, das sich mit ... respiratorischen Funktionen und anderer klinischer Parameter. ... das sich auf den ungedeckten medizinischen Bedarf ...
(Date:2/11/2016)... - Cardiac Marker Diagnostic ... and Cancer Therapy. - European Point of Care ... - Key Diagnostic Testing Markets. - Molecular ... Genetic Testing. - Molecular Diagnostics in Infectious Disease ... Diagnostic Products World Markets. - Point of Care ...
(Date:2/11/2016)... LONDON , Feb. 11, 2016 Stem ... that are characterized by self-renewal and the capacity to ... a relatively new discovery, as the first mouse embryonic ... it was not until 1995 that the first culturing ... pluripotent stem cells were not produced until 2006 As ...
Breaking Medicine Technology: